{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:46:13Z","timestamp":1786992373853,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017480","name":"Chang Bing Show Chwan Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007632","name":"Changhua Christian Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013227","name":"Health Promotion Administration, Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014477","name":"National Health Insurance Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jfma.2025.10.020","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:46:30Z","timestamp":1761104790000},"page":"S130-S140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S2","title":["Changhua Integrated Program to Stop HCV Infection (CHIPS\u2013C): A county-wide model for integrated HCV elimination in Taiwan"],"prefix":"10.1016","volume":"124","author":[{"given":"Chih-Chao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ling","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Wen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbie Ting-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Ming-Fang","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam Li-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8586-0277","authenticated-orcid":false,"given":"Chen-Yang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Chih","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dih-Ling","family":"Luh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Hui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony Hsiu-Hsi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-387X","authenticated-orcid":false,"given":"Yen-Po","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2025.10.020_bib1","series-title":"Implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022\u20132030: report on progress and gaps 2024","year":"2024"},{"key":"10.1016\/j.jfma.2025.10.020_bib2","series-title":"Global hepatitis report 2024: action for access in low- and middle-income countries","year":"2024"},{"issue":"Suppl 3","key":"10.1016\/j.jfma.2025.10.020_bib3","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1093\/infdis\/jiad016","article-title":"Policy and strategy for Hepatitis C virus elimination at the national level: experience in Taiwan","volume":"228","author":"Chien","year":"2023","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jfma.2025.10.020_bib5","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.27969","article-title":"World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma","volume":"62","author":"de Martel","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2025.10.020_bib7","series-title":"Taiwan hepatitis C policy guideline","year":"2018"},{"issue":"3","key":"10.1016\/j.jfma.2025.10.020_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0038-1666841","article-title":"The MicroElimination approach to eliminating hepatitis C: strategic and operational considerations","volume":"38","author":"Lazarus","year":"2018","journal-title":"Semin Liver Dis"},{"issue":"8","key":"10.1016\/j.jfma.2025.10.020_bib9","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jiph.2023.05.019","article-title":"A new collaborative care approach toward hepatitis C elimination in marginalized populations","volume":"16","author":"Su","year":"2023","journal-title":"J Infect Public Health"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.020_bib10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s12072-023-10605-x","article-title":"Planning, implementing, and evaluating hepatitis C virus elimination via collaborative community-based care cascade: age-period-cohort model for estimating demand from antecedent anti-HCV survey","volume":"18","author":"Lin","year":"2024","journal-title":"Hepatol Int"},{"issue":"Suppl 2","key":"10.1016\/j.jfma.2025.10.020_bib11","doi-asserted-by":"crossref","first-page":"S314","DOI":"10.1016\/S0168-8227(14)70736-3","article-title":"Overcoming disparities in diabetes care: eight years' experience changing the diabetes care system in Changhua, Taiwan","volume":"106","author":"Yeh","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.jfma.2025.10.020_bib12","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/hep.26703","article-title":"Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan","volume":"59","author":"Yeh","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jfma.2025.10.020_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jmv.1890460314","article-title":"Injection with nondisposable needles as an important route for transmission of acute community-acquired hepatitis C virus infection in Taiwan","volume":"46","author":"Chen","year":"1995","journal-title":"J Med Virol"},{"key":"10.1016\/j.jfma.2025.10.020_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1440-1746.1993.tb01690.x","article-title":"Acute post-transfusion hepatitis C in Taiwan: evaluation of two generation of hepatitis C virus diagnostic enzyme immunoassay","volume":"8","author":"Lee","year":"1993","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jfma.2025.10.020_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1053\/j.ajkd.2021.03.017","article-title":"Changhua Hepatitis C elimination task force. Elimination of hepatitis C virus in a dialysis population: a collaborative care model in Taiwan","volume":"78","author":"Hu","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.020_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jinf.2023.05.016","article-title":"Enhancing testing and treatment uptake of HCV cascade care for the diabetes population via an integrated community-based shared care model","volume":"87","author":"Hu","year":"2023","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.jfma.2025.10.020_bib17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.14309\/ajg.0000000000002624","article-title":"Changhua hepatitis C elimination task force. Using the diabetes care system for a county-wide hepatitis C elimination: an integrated community-based shared care model in Taiwan","volume":"119","author":"Hu","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.020_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3390\/jcm11020423","article-title":"Micro-elimination of hepatitis C among patients with kidney disease by using electronic reminder System-A hospital-based experience","volume":"11","author":"Su","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.020_bib19","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S1473-3099(19)30524-9","article-title":"Tuberculosis, HIV, and viral hepatitis diagnostics in eastern Europe and central Asia: high time for integrated and people-centred services","volume":"20","author":"Dara","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jfma.2025.10.020_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.jfma.2025.10.020_bib21","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"Negro","year":"2015","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jfma.2025.10.020_bib22","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1053\/j.gastro.2016.02.039","article-title":"Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden","volume":"150","author":"Younossi","year":"2016","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.jfma.2025.10.020_bib23","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S2468-1253(19)30227-4","article-title":"Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study","volume":"4","author":"Lee","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.jfma.2025.10.020_bib24","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/hep.21208","article-title":"Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection","volume":"43","author":"Lai","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jfma.2025.10.020_bib25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis","volume":"49","author":"White","year":"2008","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jfma.2025.10.020_bib26","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.29505","article-title":"Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD","volume":"67","author":"Park","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jfma.2025.10.020_bib27","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1093\/cid\/ciaa612","article-title":"Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: a systematic review and meta-analysis","volume":"73","author":"Grebely","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jfma.2025.10.020_bib28","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/cid\/cix1007","article-title":"Declining Hepatitis C Virus (HCV) incidence in Dutch human immunodeficiency virus-positive men who have sex with men after unrestricted access to HCV therapy","volume":"66","author":"Boerekamps","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.jfma.2025.10.020_bib29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S2468-1253(21)00077-7","article-title":"Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study","volume":"6","author":"Hajarizadeh","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.jfma.2025.10.020_bib30","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1473-3099(18)30469-9","article-title":"Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis","volume":"18","author":"Stone","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.jfma.2025.10.020_bib31","first-page":"877","article-title":"The Egyptian journey from having the highest prevalence of hepatitis C virus to being the first to achieve \"gold tier\" in conquering the disease","volume":"37","author":"Abosheaishaa","year":"2024","journal-title":"SAVE Proc"},{"issue":"4","key":"10.1016\/j.jfma.2025.10.020_bib32","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jhep.2019.11.004","article-title":"An educate, test and treat model towards elimination of hepatitis C infection in Egypt: feasibility and effectiveness in 73 villages","volume":"72","author":"Shiha","year":"2020","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jfma.2025.10.020_bib33","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/liv.14974","article-title":"Micro-elimination of hepatitis C among people living with HIV in Egypt","volume":"41","author":"Mohamed","year":"2021","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.jfma.2025.10.020_bib34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jiph.2012.12.003","article-title":"Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases","volume":"6","author":"Mohamed","year":"2013","journal-title":"J Infect Public Health"},{"issue":"4","key":"10.1016\/j.jfma.2025.10.020_bib35","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jhep.2019.11.019","article-title":"Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia","volume":"72","author":"Averhoff","year":"2020","journal-title":"J Hepatol"},{"issue":"30","key":"10.1016\/j.jfma.2025.10.020_bib36","doi-asserted-by":"crossref","first-page":"660","DOI":"10.15585\/mmwr.mm7330a1","article-title":"Progress toward the elimination of hepatitis B and hepatitis C in the country of Georgia, April 2015-April 2024","volume":"73","author":"Tohme","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"29","key":"10.1016\/j.jfma.2025.10.020_bib37","doi-asserted-by":"crossref","first-page":"637","DOI":"10.15585\/mmwr.mm6829a2","article-title":"Progress in testing for and treatment of hepatitis C virus infection among persons who inject drugs - georgia, 2018","volume":"68","author":"Stvilia","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.jfma.2025.10.020_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262935","article-title":"Risk factors and genotype distribution of hepatitis C virus in Georgia: a nationwide population-based survey","volume":"17","author":"Baliashvili","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jfma.2025.10.020_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41124-018-0040-9","article-title":"Strategies for achieving viral hepatitis C micro-elimination in the Netherlands","volume":"3","author":"Kracht","year":"2018","journal-title":"Hepatol Med Pol"},{"issue":"5","key":"10.1016\/j.jfma.2025.10.020_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126031","article-title":"Comparison stratagems of post-screening management of Anti-HCV-Positive community residents: simple notification, active referral, or accessible medical care","volume":"10","author":"Kuo","year":"2015","journal-title":"PLoS One"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625005649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625005649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:42:31Z","timestamp":1768452151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664625005649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":38,"alternative-id":["S0929664625005649"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2025.10.020","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changhua Integrated Program to Stop HCV Infection (CHIPS\u2013C): A county-wide model for integrated HCV elimination in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2025.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}